CHARACTERIZING CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTED ONLY BY SYSTEMATIC BIOPSY IN AN MRI-TARGETED BIOPSY PARADIGM

被引：0
|
作者：
Sean, Fletcher A. [1 ,2 ]
Mark, Alshak N. [1 ,2 ]
Jing Yuezhou [1 ,2 ]
Nirmish, Singla [1 ,2 ]
Misop, Han [1 ,2 ]
Mohamad, Allaf E. [1 ,2 ]
Christian, Pavlovich P. [1 ,2 ]
机构：
[1] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
198
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [21] Re: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2020, 204 (06): : 1382 - 1383
  • [22] A systematic Evidence Analysis for Comparison of MRI-targeted Biopsy versus systematic Biopsy in the Diagnosis of Prostate cancer
    Sigle, A.
    Jilg, C. A.
    Schmidt, S.
    Miernik, A.
    UROLOGE, 2020, 59 (02): : 185 - 188
  • [23] Can we predict for missed clinically significant prostate cancers on MRI-Targeted biopsy alone?
    Tsang, W. C.
    Wang, K.
    Quek, A. J. Y.
    Wang, Z.
    Chiong, E.
    Wu, Q.
    EUROPEAN UROLOGY, 2023, 83 : S244 - S244
  • [24] SYSTEMATIC REVIEW AND META-ANALYSIS OF SIGNIFICANT CANCER DETECTION BY MRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC BIOPSY
    Kasivisvanathan, Veeru
    Stabile, Armando
    Neves, Joana
    Giganti, Francesco
    Valerio, Massimo
    Shanmugabavan, Yaalini
    Clement, Keiran
    Sarkar, Debashis
    Philippou, Yiannis
    Thurtle, David
    Deeks, Jon
    Emberton, Mark
    Takwoingi, Yemisi
    Moore, Caroline
    JOURNAL OF UROLOGY, 2019, 201 (04): : E341 - E341
  • [25] CAN WE PREDICT FOR MISSED CLINICALLY SIGNIFICANT PROSTATE CANCERS ON MRI-TARGETED BIOPSY ALONE?
    Tsang, Woon Chau
    Wang, Kaiying
    Quek, Abner
    Wang, Ziting
    Chiong, Edmund
    Wu, Qinghui
    JOURNAL OF UROLOGY, 2023, 209 : E553 - E553
  • [26] Developments in MRI-targeted prostate biopsy
    Norris, Joseph M.
    Kinnaird, Adam
    Margolis, Daniel J.
    Padhani, Anwar R.
    Walz, Jochen
    Kasivisvanathan, Veeru
    CURRENT OPINION IN UROLOGY, 2020, 30 (01) : 1 - 8
  • [27] WHY DOES MRI-TARGETED BIOPSY MISS CLINICALLY SIGNIFICANT CANCERS?
    Williams, Cheyenne
    Ahdoot, Michael
    Daneshvar, Michael
    Gomella, Patrick
    Owens-Walton, Jeunice
    Khondakar, Nabila
    OConnor, Luke
    Yerram, Nitin
    Mehralivand, Sherif
    Merino, Maria
    Wood, Bradford
    Choyke, Peter
    Turkbey, Baris
    Pinto, Peter
    JOURNAL OF UROLOGY, 2021, 206 : E1004 - E1005
  • [28] MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
    Eklund, Martin
    Jaderling, Fredrik
    Discacciati, Andrea
    Bergman, Martin
    Annerstedt, Magnus
    Aly, Markus
    Glaessgen, Axel
    Carlsson, Stefan
    Groenberg, Henrik
    Nordstroem, Tobias
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 908 - 920
  • [29] Can we predict for missed clinically significant prostate cancers on MRI-Targeted biopsy alone?
    Tsang, Woon Chau
    Wang, Kaiying
    Quek, Abner Jing Yan
    Wang, Ziting
    Chiong, A. Edmund
    Wu, Qing Hui
    BJU INTERNATIONAL, 2023, 132 : 24 - 25
  • [30] After PSA screening, MRI-targeted vs. systematic biopsy detected fewer clinically insignificant prostate cancers
    Hoffman, Richard M.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (04) : JC44 - JC44
12345